Nexis GC-2030 Brand New Industry Standard Gas Chromatograph

Mass spectrometry & spectroscopy

Nexis GC-2030 Brand New Industry Standard Gas Chromatograph

22 Jun, 2017

Published over 9 years ago. See the latest and most current information on Mass spectrometry & spectroscopy.

The Nexis GC-2030 system is designed with the analyst in mind. The touch panel interface features clear graphics that display information instantly whenever needed. The user-friendly interface leaves the operator free to focus on obtaining optimal analytical results.

Routine analysis are convenient with the ClickTek connectors allowing for tool- free column installation and one touch inlet maintenance.

Nexis GC-2030 combines the World's Highest* Sensitivity and Reproducibility (*As of May 2017, according to a Shimadzu survey). It provides exceptional extensibility and productivity with advanced flow technology and faster analysis with hydrogen carrier gas.

In addition, Nexis GC-2030 offers various advanced functions improving energy efficiency such as column temperature control function.

The Options for Expanding Your Productivity:

Inlets

Split/Splitless Injector

On-Column Injection Unit

Direct Injection Unit

Programmed Temperature Vaporisation Injector

Detectors

Flame Ionisation Detector

Flame Photometric Detector

Thermal Conductivity Detector

Flame Thermionic Detector

Electron Capture Detector

Barrier Discharge Ionisation Detector

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Sweco wins multi-year Netherlands water infrastructure framework to strengthen flood resilience and water quality
Explore more Arrow
Petro Online
Helping fuel and lubricant laboratories stay ahead of industry changes
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow